Trial intelligence / Profile preview

Lupron Depot in Central Precocious Puberty

NCT00660010Phase 3Completed

Sponsor
Abbott Laboratories
Start
Jan 1991
Primary completion
Apr 2009
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of leuprolide in central precocious puberty (CPP), sponsored by Abbott Laboratories. Started Jan 1991; status: completed.

02

Drugs

leuprolide
03

Conditions

central precocious puberty (CPP)

Beyond the preview

Go deeper on NCT00660010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00660010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call